Bit.bio logo

Bit.bio

Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.

3

Funding Rounds

$183.9m

Money raised

Overview

Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.

Funding series

Funding Series Analysis

The company Bit.bio has raised a total of $83.5m in funding over 3 rounds.

Key Insights:

  • Bio.Bit Series A round, June 2020: $41.5m
  • bit.bio June 2020 Series A Funding Round: $42m
  • Bitbio Seed round, November 2017: $350k
Bit.bio logo
Bio.Bit Series A round, June 2020 $41.5m
Bit.bio logo
bit.bio June 2020 Series A Funding Round $42m
Bit.bio logo
Bitbio Seed round, November 2017 $350k

Industries

Bit.bio is active in the following industries:
  • Biology
  • Biomedical engineering
  • Engineering
  • Technology
  • Biotechnology
  • Regenerative medicine
  • Healthcare
  • Tissue engineering
  • Cell therapy
  • Allogeneic cell therapy
  • Industrial Biotechnology
  • Immunotherapy
  • Business intelligence (BI)
  • Health technology
  • Deep Tech